IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM PAR
Total 13F shares
10,407,305
Share change
-1,766,188
Total reported value
$27,787,451
Price per share
$2.67
Number of holders
52
Value change
-$4,516,078
Number of buys
28
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q2 2019

As of 30 Jun 2019, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,407,305 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, NATIXIS, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, OxFORD Asset Management LLP, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.